Q32 Bio Inc.
QTTB
$1.74
$0.084.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.03M | -14.19M | -17.60M | -16.98M | 1.03M |
| Total Depreciation and Amortization | 119.00K | 120.00K | 123.00K | 121.00K | 123.00K |
| Total Amortization of Deferred Charges | 48.00K | 49.00K | 50.00K | 66.00K | 29.00K |
| Total Other Non-Cash Items | 607.00K | 1.62M | 1.18M | 1.33M | -15.16M |
| Change in Net Operating Assets | -2.23M | 974.00K | -3.28M | -6.76M | -576.00K |
| Cash from Operations | -12.48M | -11.43M | -19.52M | -22.21M | -14.55M |
| Capital Expenditure | -- | -2.00K | -58.00K | -15.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 10.00M | 9.90M | 97.00K |
| Cash from Investing | -- | -2.00K | 9.94M | 9.89M | 97.00K |
| Total Debt Issued | -- | -53.16M | 0.00 | 0.00 | 7.00M |
| Total Debt Repaid | -- | 8.71M | 0.00 | -5.90M | -- |
| Issuance of Common Stock | -- | 317.00K | 997.00K | 380.00K | 42.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 44.44M | -- | -- | 50.35M |
| Cash from Financing | -- | 317.00K | 997.00K | -5.52M | 99.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.48M | -11.11M | -8.58M | -17.85M | 84.89M |